pyrazines has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavaletti, G; Gilardini, A; Marmiroli, P | 1 |
| Kuwabara, S | 1 |
2 review(s) available for pyrazines and Demyelinating Diseases
| Article | Year |
|---|---|
Proteasome inhibition: a promising strategy for treating cancer, but what about neurotoxicity?
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Demyelinating Diseases; Humans; Myelin Sheath; Neoplasms; Neurotoxicity Syndromes; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines | 2008 |
[New treatment strategy for Crow-Fukase (POEMS) syndrome].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Combined Modality Therapy; Demyelinating Diseases; Humans; Lenalidomide; Melphalan; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Pyrazines; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2010 |